J. Teixeira, S. Maheswaran, and P. K. Donahoe, Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications, Endocrine Reviews, vol.22, issue.5, pp.657-674, 2001.

F. Ichas, N. Faucounau, R. Stoll, and R. Maraud, Action of testosterone on the anti-M?llerian activity of the chick embryonic testis assayed in vivo by organotypic grafting, Anatomy and Embryology, vol.190, issue.3, 1994.

D. Dewailly, C. Y. Andersen, A. Balen, F. Broekmans, N. Dilaver et al., The physiology and clinical utility of anti-Müllerian hormone in women, Human Reproduction Update, vol.20, issue.3, pp.370-385, 2014.

C. A. Christian and S. M. Moenter, The Neurobiology of Preovulatory and Estradiol-Induced Gonadotropin-Releasing Hormone Surges, Endocrine Reviews, vol.31, issue.4, pp.544-577, 2010.

P. Giacobini, J. Parkash, C. Campagne, A. Messina, F. Casoni et al., Brain Endothelial Cells Control Fertility through Ovarian-Steroid?Dependent Release of Semaphorin 3A, PLoS Biology, vol.12, issue.3, p.e1001808, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02132635

T. Kim, M. Do, and M. A. Lawson, Translational control of gene expression in the gonadotrope, Molecular and Cellular Endocrinology, vol.385, issue.1-2, pp.78-87, 2014.

G. Garrel, C. Racine, D. L?hôte, C. Denoyelle, C. J. Guigon et al., L?hormone anti-müllérienne : un nouveau régulateur des cellules gonadotropes hypophysaires, médecine/sciences, vol.32, issue.12, pp.1076-1078, 2016.

J. Hugon, S. Ouzounian, and S. Christin-maître, Hormone antimüllérienne : du gène à la protéine, sa place en clinique, Annales d'Endocrinologie, vol.71, issue.2, pp.83-88, 2010.

J. Picard and N. Josso, Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor, Molecular and Cellular Endocrinology, vol.34, issue.1, pp.23-29, 1984.

R. Rey, C. Lukas-croisier, C. Lasala, and P. Bedecarrás, AMH/MIS: what we know already about the gene, the protein and its regulation, Molecular and Cellular Endocrinology, vol.211, issue.1-2, pp.21-31, 2003.

N. Josso, N. Di-clemente, and L. Gouédard, Anti-Müllerian hormone and its receptors, Molecular and Cellular Endocrinology, vol.179, issue.1-2, pp.25-32, 2001.

M. Rzeszowska, A. Leszcz, L. Putowski, M. Ha?abi?, J. Tkaczuk-w?ach et al., Anti-Müllerian hormone: structure, properties and appliance, Ginekologia Polska, vol.87, issue.9, pp.669-674, 2016.

J. V. Jeppesen, R. A. Anderson, T. W. Kelsey, S. L. Christiansen, S. G. Kristensen et al., Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection, Molecular Human Reproduction, vol.19, issue.8, pp.519-527, 2013.

R. R. Behringer, 5 The in Vivo Roles of Müllerian-inhibiting Substance, Current Topics in Developmental Biology, pp.171-187, 1994.

W. Boron and E. Boulpaep, Medical Physiology: A Cellular and Molecular Approaoch, 2017.

R. J. Nelson, An Introduction to Behavioral Endocrinology, Fourth Edition, p.9

N. Lebeurrier, S. Launay, R. Macrez, E. Maubert, H. Legros et al., Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin, Journal of Cell Science, vol.121, issue.20, pp.3357-3365, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02299069

P. Wang, A. Protheroe, A. N. Clarkson, F. Imhoff, K. Koishi et al., Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior, Proceedings of the National Academy of Sciences, vol.106, issue.17, pp.7203-7208, 2009.

S. Catteau-jonard, D. Dewailly, V. Prévot, I. Cimino, and P. Giacobini, L?hormone anti-müllerienne, médecine/sciences, vol.32, issue.5, pp.441-444, 2016.

N. Josso, C. Belville, N. Di-clemente, and J. Picard, AMH and AMH receptor defects in persistent Müllerian duct syndrome, Human Reproduction Update, vol.11, issue.4, pp.351-356, 2005.

E. Thibault, S. Mirallié, Y. Al-hussein, M. Jean, O. Bouchot et al., Anti-mullerian hormone as a spermatogenesis marker in non-obstructive azoospermia?, Fertility and Sterility, vol.80, p.239, 2003.

J. Young, P. Chanson, S. Salenave, M. Noël, S. Brailly et al., Testicular Anti-Müllerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.2, pp.724-728, 2005.

T. Eldar-geva, A. Ben-chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz et al., Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome, Human Reproduction, vol.20, issue.11, pp.3178-3183, 2005.

L. Aksglaede, I. A. Olesen, E. Carlsen, J. H. Petersen, A. Juul et al., Serum concentration of anti-Müllerian hormone is not associated with semen quality, Andrology, vol.6, issue.2, pp.286-292, 2017.

J. M. Andersen, H. Herning, O. Witczak, and T. B. Haugen, Anti-Müllerian hormone in seminal plasma and serum: association with sperm count and sperm motility, Human Reproduction, vol.31, issue.8, pp.1662-1667, 2016.

S. Hamamah, T. Anahory, A. Ferrière, V. Loup, L. Reyftmann et al., Solutions thérapeutiques pour les infertilités masculines, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol.38, pp.F58-F64, 2009.

E. A. Mcgee and A. J. Hsueh, Initial and Cyclic Recruitment of Ovarian Follicles*, Endocrine Reviews, vol.21, issue.2, pp.200-214, 2000.

A. L. Durlinger, J. A. Visser, and A. P. Themmen, Regulation of ovarian function: the role of anti-Mullerian hormone, Reproduction, pp.601-609, 2002.

N. Di-clemente, A. Seroka, C. Sonigo, A. Pierre, J. Taieb et al., L'hormone anti-müllérienne : nouveautés physiologiques et expérimentales chez la femme, vol.16, p.13, 2019.

J. A. Visser, I. Schipper, J. S. Laven, and A. P. Themmen, Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency, Nature Reviews Endocrinology, vol.8, issue.6, pp.331-341, 2012.

A. L. Durlinger, P. Kramer, B. Karels, F. H. De-jong, J. T. Uilenbroek et al., Control of Primordial Follicle Recruitment by Anti-Mu?llerian Hormone in the Mouse Ovary1, Endocrinology, vol.140, issue.12, pp.5789-5796, 1999.

L. Pellatt, S. Rice, N. Dilaver, A. Heshri, R. Galea et al., Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells, Fertility and Sterility, vol.96, issue.5, pp.1246-1251.e1, 2011.

A. De-vet, J. S. Laven, F. H. De-jong, A. P. Themmen, and B. C. Fauser, Antimüllerian hormone serum levels: a putative marker for ovarian aging, Fertility and Sterility, vol.77, issue.2, pp.357-362, 2002.

A. Maheshwari, P. Fowler, and S. Bhattacharya, Assessment of ovarian reserve?should we perform tests of ovarian reserve routinely?, Human Reproduction, vol.21, issue.11, pp.2729-2735, 2006.

A. Fouquet, S. Catteau-jonard, M. Peigné, P. Pigny, and D. Dewailly, Usefulness and indications of AMH assay in women, Annales de biologie clinique, vol.72, issue.6, pp.681-688, 2014.

J. A. Visser, A. L. Durlinger, I. J. Peters, E. R. Van-den-heuvel, U. M. Rose et al., Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mu?llerian Hormone Null Mice, Endocrinology, vol.148, issue.5, pp.2301-2308, 2007.

I. B. Carlsson, Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro, Human Reproduction, vol.21, issue.9, pp.2223-2227, 2006.

T. W. Kelsey, P. Wright, S. M. Nelson, R. A. Anderson, and W. H. Wallace, A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause, PLoS ONE, vol.6, issue.7, p.e22024, 2011.

A. Andersson, J. M. Ller, and N. E. Skakkeb, Different Roles of Prepubertal and Postpubertal Germ Cells and Sertoli Cells in the Regulation of Serum Inhibin B Levels, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.12, pp.4451-4458, 1998.

L. Fong, S. Visser, J. A. Welt, C. K. De-rijke, Y. B. Eijkemans et al., Serum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood, The Journal of Clinical Endocrinology & Metabolism. 1 déc, vol.97, issue.12, pp.4650-4655, 2012.

D. B. Seifer, V. L. Baker, and B. Leader, Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States, Fertility and Sterility, vol.95, issue.2, pp.747-750, 2011.

F. R. Tehrani, M. Solaymani-dodaran, M. Tohidi, M. R. Gohari, and F. Azizi, Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.2, pp.729-735, 2013.

M. Dólleman, M. J. Faddy, J. Van-disseldorp, Y. T. Van-der-schouw, C. M. Messow et al., The Relationship Between Anti-Müllerian Hormone in Women Receiving Fertility Assessments and Age at Menopause in Subfertile Women: Evidence From Large Population Studies, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.5, pp.1946-1953, 2013.

L. Marca, A. Grisendi, V. Griesinger, and G. , How Much Does AMH Really Vary in Normal Women?, International Journal of Endocrinology, vol.2013, pp.1-8, 2013.

S. Kallio, J. Puurunen, A. Ruokonen, T. Vaskivuo, T. Piltonen et al., Antimüllerian hormone levels decrease in women using combined contraception independently of administration route, Fertility and Sterility, vol.99, issue.5, pp.1305-1310, 2013.

C. Dechanet, T. Anahory, J. C. Mathieu-daude, X. Quantin, L. Reyftmann et al., Effects of cigarette smoking on reproduction, Human Reproduction Update, vol.17, issue.1, pp.76-95, 2010.

T. Freour, L. Dessolle, M. Jean, D. Masson, and P. Barriere, Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF, Reproductive BioMedicine Online, vol.20, issue.6, pp.857-860, 2010.

P. Lehmann, M. P. Vélez, J. Saumet, L. Lapensée, W. Jamal et al., Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF, Journal of Assisted Reproduction and Genetics, vol.31, issue.4, pp.493-498, 2014.

A. N. Andersen, H. Witjes, K. Gordon, and B. Mannaerts, Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment, Human Reproduction, vol.26, issue.12, pp.3413-3423, 2011.

S. L. Broer, J. Van-disseldorp, K. A. Broeze, M. Dolleman, B. C. Opmeer et al., Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach, Human Reproduction Update, vol.19, issue.1, pp.26-36, 2013.

L. Casadei, C. Manicuti, F. Puca, A. Madrigale, E. Emidi et al., Can anti-Müllerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility?, Journal of Obstetrics and Gynaecology, vol.33, issue.8, pp.857-861, 2013.

M. F. Patricia, Évaluation des systèmes implantables de neurostimulation médullaire par la Haute Autorité de santé (HAS) en France, Chirurgie de la douleur, pp.143-148, 2014.

D. Dewailly, M. E. Lujan, E. Carmina, M. I. Cedars, J. I. Laven et al., Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society, Human Reproduction Update, vol.20, issue.3, pp.334-352, 2013.

S. M. Nelson and A. La-marca, The journey from the old to the new AMH assay: how to avoid getting lost in the values, Reproductive BioMedicine Online, vol.23, issue.4, pp.411-420, 2011.

B. Meczekalski, A. Czyzyk, M. Kunicki, A. Podfigurna-stopa, L. Plociennik et al., Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment, Journal of Endocrinological Investigation, vol.39, issue.11, pp.1259-1265, 2016.

B. Aydogan and S. Mirkin, The utility of measuring anti-Müllerian hormone in predicting menopause, Climacteric, vol.18, issue.6, pp.777-789, 2015.

R. Slama, La fertilité des couples en France, p.5

L. Marca, A. Broekmans, F. J. Volpe, A. Fauser, and B. C. , Anti-Mullerian hormone (AMH): what do we still need to know?, Macklon NS, on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology -AMH Round Table, vol.24, pp.2264-75, 2009.

K. R. Hansen, G. M. Hodnett, N. Knowlton, and L. B. Craig, Correlation of ovarian reserve tests with histologically determined primordial follicle number, Fertility and Sterility, vol.95, issue.1, pp.170-175, 2011.

H. J. Park, G. H. Lee, D. S. Gong, T. K. Yoon, and W. S. Lee, The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response, Clin Exp Reprod Med, vol.43, issue.3, p.139, 2016.

R. Fleming, D. B. Seifer, J. L. Frattarelli, and J. Ruman, Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reproductive BioMedicine Online, vol.31, pp.486-96, 2015.

A. P. Ferraretti, L. Marca, A. Fauser, B. Tarlatzis, B. Nargund et al., ESHRE consensus on the definition of « poor response » to ovarian stimulation for in vitro fertilization: the Bologna criteria, Human Reproduction. 1 juill, vol.26, issue.7, pp.1616-1640, 2011.

N. Andersen, A. Nelson, S. M. Fauser, B. García-velasco, J. A. Klein et al., Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial, Fertility and Sterility. févr, vol.107, issue.2, pp.387-396, 2017.

B. Coskun, B. Dilbaz, B. Karadag, B. Coskun, Y. A. Tohma et al., The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility, Taiwanese Journal of Obstetrics and Gynecology, vol.57, issue.5, pp.713-717, 2018.

N. Gleicher, A. Weghofer, and D. H. Barad, Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility, Reproductive Biology and Endocrinology, vol.8, issue.1, p.64, 2010.

S. Wang, Y. Zhang, V. Mensah, W. J. Huber, Y. Huang et al., Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?, Journal of Ovarian Research, vol.11, issue.1, 2018.

S. J. Morin, G. Patounakis, C. R. Juneau, S. A. Neal, R. T. Scott et al., Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance, Human Reproduction, vol.33, issue.8, pp.1489-1498, 2018.

S. Sirmans and K. Pate, Epidemiology, diagnosis, and management of polycystic ovary syndrome, Clinical Epidemiology, vol.1, p.1, 2013.

, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Human Reproduction, vol.19, issue.1, pp.41-47, 2004.

D. Dewailly, H. Gronier, E. Poncelet, G. Robin, M. Leroy et al., Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries, Human Reproduction, vol.26, issue.11, pp.3123-3129, 2011.

M. E. Lujan, B. Y. Jarrett, E. D. Brooks, J. K. Reines, A. K. Peppin et al., Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume, Human Reproduction, vol.28, issue.5, pp.1361-1368, 2013.

R. Azziz, E. Carmina, D. E. Dewailly, E. Diamanti-kandarakis, H. F. Escobar-morreale et al., The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertility and Sterility, vol.91, issue.2, pp.456-488, 2009.

A. E. Taylor, B. Mccourt, K. A. Martin, E. J. Anderson, J. M. Adams et al., Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1, The Journal of Clinical Endocrinology & Metabolism, vol.82, issue.7, pp.2248-2256, 1997.

P. Pigny, E. Merlen, Y. Robert, C. Cortet-rudelli, C. Decanter et al., Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.12, pp.5957-5962, 2003.

B. Solorzano, C. M. Beller, J. P. Abshire, M. Y. Collins, J. S. Mccartney et al., Neuroendocrine dysfunction in polycystic ovary syndrome, Steroids. mars, vol.77, issue.4, pp.332-339, 2012.

C. K. Shapiro-mendoza, W. D. Barfield, Z. Henderson, A. James, J. L. Howse et al., CDC Grand Rounds: Public Health Strategies to Prevent Preterm Birth, MMWR. Morbidity and Mortality Weekly Report, vol.65, issue.32, pp.826-830, 2016.

J. Y. Hsu, K. E. James, C. L. Bormann, P. K. Donahoe, D. Pépin et al., Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.103, issue.11, pp.4187-4196, 2018.

A. Köninger, A. Kampmeier, B. Schmidt, M. Frank, T. Strowitzki et al., Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome, Reproductive BioMedicine Online, vol.37, issue.3, pp.367-374, 2018.

L. Bessiène, M. Lombès, and C. Bouvattier, Controverses et challenges sur le développement sexuel différent (DSD), Annales d'Endocrinologie, vol.79, pp.S22-S30, 2018.

L. Johansen, M. Hagen, C. P. Johannsen, T. H. Main, K. M. Picard et al., Anti-Müllerian Hormone and Its Clinical Use in Pediatrics with Special Emphasis on Disorders of Sex Development, International Journal of Endocrinology, vol.2013, pp.1-10, 2013.

N. Y. Edelsztein, R. P. Grinspon, H. F. Schteingart, and R. A. Rey, Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis, International Journal of Pediatric Endocrinology, vol.2016, issue.1, p.20, 2016.

S. F. Ahmed, J. C. Achermann, W. Arlt, A. Balen, G. Conway et al., Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015), Clinical Endocrinology, vol.84, issue.5, pp.771-788, 2015.

N. Hoog-labouret and F. Merlet, Conséquences des traitements des cancers et préservation de la fertilité, Oncologie, vol.15, issue.5, pp.263-270, 2013.

M. Comtet, J. Benard, and M. Grynberg, Préservation de la fertilité féminine. Gynécologie

D. Sur, LAS VEGAS SANDS CORP., a Nevada corporation, Plaintiff, v. UKNOWN REGISTRANTS OF www.wn0000.com, www.wn1111.com, www.wn2222.com, www.wn3333.com, www.wn4444.com, www.wn5555.com, www.wn6666.com, www.wn7777.com, www.wn8888.com, www.wn9999.com, www.112211.com, www.4456888.com, www.4489888.com, www.001148.com, and www.2289888.com, Defendants., Gaming Law Review and Economics, vol.20, issue.10, pp.859-868, 2016.

R. A. Anderson, M. Rosendahl, T. W. Kelsey, and D. A. Cameron, Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer, European Journal of Cancer, vol.49, issue.16, pp.3404-3411, 2013.

M. Peigné and C. Decanter, Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review, Reproductive Biology and Endocrinology, vol.12, issue.1, p.26, 2014.

H. Kim, J. Choi, C. S. Park, M. Seong, S. Hong et al., Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery, Endocrine Connections, vol.7, issue.8, pp.949-956, 2018.

C. E. Dunlop and R. A. Anderson, Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women, Maturitas, vol.80, issue.3, pp.245-250, 2015.

E. J. Chow, K. L. Stratton, W. M. Leisenring, K. C. Oeffinger, C. A. Sklar et al., Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort, The Lancet Oncology, vol.17, issue.5, pp.567-576, 2016.

S. N. Nielsen, A. N. Andersen, K. T. Schmidt, C. Rechnitzer, K. Schmiegelow et al., A 10-year follow up of reproductive function in women treated for childhood cancer, Reproductive BioMedicine Online, vol.27, issue.2, pp.192-200, 2013.

C. B. Lambalk, Anti-Müllerian hormone, the holy grail for fertility counselling in the general population?, Human Reproduction, vol.30, issue.10, pp.2257-2258, 2015.

M. H. Berg, A. Overbeek, C. B. Lambalk, G. Kaspers, D. Bresters et al., Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve, Human Reproduction. 1 août, vol.33, issue.8, pp.1474-88, 2018.

R. A. Anderson, E. Anckaert, E. Bosch, D. Dewailly, C. E. Dunlop et al., Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool, Fertility and Sterility, vol.103, issue.4, pp.1074-1080.e4, 2015.

. Serment-d&apos;hippocrate, HIPPOCRATE LA NATURE DE L'HOMME/ ??????????? ???? ?????? ????????, Hippocrate La nature de l'homme

J. Wittmann, « C?est poète que je veux être ! C?est poète que je suis ! ». La place paradoxale de la poésie dans la carrière littéraire de Gide, La poésie, entre vers et prose, pp.139-149

, 3.1.1. Emploi dans le secteur de la santé et des services sociaux en pourcentage de l'emploi civil total, 1995 et 2009 (ou année la plus proche)

. Prâevost, Â. M. Chomprâe, A. Deleyre, J. Green, A. Meusnier-de-querlon et al., Histoire gâenâerale des voyages, ou, Nouvelle collection de toutes les relations de voyages par mer et par terre, qui ont âetâe publiâees jusqu'áa present dans les diffâerentes langues de toutes les nations connues : contenant ce qu'il y a de plus remarquable, de plus utile et de mieux averâe dans les pays ou les voyageurs ont penetrâe : touchant leur situation, leur âetendue, leurs limites, leurs divisions, leur climat, leur terroir, leurs productions, leurs lacs, leurs rivieres, leurs montagnes, leurs mines, leurs citâes & leurs principales villes, leurs ports, leurs rades, leurs edifices, &c. : avec les moeurs et les usages des habitans, leur religion, leur gouvernement, leurs arts et leurs sciences, leur commerce et leurs manufactures : pour former un systâeme complet d'histoire et de gâeographie moderne, qui representera l'âetat actuel de toutes les nations : enrichi de cartes gâeographiques nouvellement composâees sur les observations les plus autentiques :, 1746.

, Graphique 10.7. Les migrants très instruits ne sont pas les plus enclins à regagner leur pays d'origine, et ce pour la plupart des pays

L. Madsen-brooks, « Je ne me suis pas perdue et ne souhaite pas que l?on me trouve ». Stratégies des femmes dans les musées de sciences en Californie (xixe-, Culture & musées, issue.30, pp.111-131, 2017.

M. Sandras, « Je ne suis pas un écrivain, je suis le poète qui chante » Les entretiens de Paul Fort avec Michel Manoll, Écrivains au micro, pp.201-15

M. Sandras, « Je ne suis pas un écrivain, je suis le poète qui chante » Les entretiens de Paul Fort avec Michel Manoll, Écrivains au micro, pp.201-15

A. Niess, Conclusion. Le spectre des deux-cents familles ?, L?hérédité en République, pp.327-328, 2012.

, Si je constate une violation de mes droits de propriété intellectuelle, que dois-je ou que puis-je faire?, 2004.